Table 2.
Mutation frequency data sets used by HIV-SEQ
| Gene | Subtype | Treatment | Number of isolatesa | Number of referencesa |
|---|---|---|---|---|
| Protease | B | Nonea | 436 | 55 |
| Protease | Non-B | Nonea | 163 | 39 |
| Protease | B | >=1 protease inhibitor | 471 | 32 |
| Protease | B | >=3 protease inhibitors | 80 | 11 |
| RT | B | Noneb | 136 | 42 |
| RT | Non-B | Noneb | 117 | 31 |
| RT | B | >=1 nucleoside RT inhibitorsc | 381 | 42 |
| RT | B | >=4 nucleoside RT inhibitorsc | 90 | 14 |
| RT | B | Non-nucleoside RT inhibitorsd | 121 | 11 |
a
These numbers are based on data through 3/1/2000. The most recent figures can be found in the ‘Release Notes’ section (http://hivdb.stanford.edu/hiv/programs.htm#ReleaseNotes).
b
Individuals may have receivod an RT inhibitor.
c
Individuals in these categories did not receive nonnucleoside RT inhibitors.
d
Individuals in this category usually also received nucleoside RT inhibitors.